Literature DB >> 17332063

Calcium-calmodulin kinase II is the common factor in calcium-dependent cardiac expression and secretion of A- and B-type natriuretic peptides.

Jarkko J Ronkainen1, Olli Vuolteenaho, Pasi Tavi.   

Abstract

Peptides derived from the precursor of A- and B-type natriuretic peptides (ANP and BNP) are powerful clinical markers of cardiac hypertrophy and dysfunction. It is known that many stimuli affecting the intracellular calcium concentration also induce ANP and BNP secretion. It was our intention to study the mechanisms by which calcium regulates the secretion of ANP and BNP. The effects of pacing and calcium-calmodulin kinase II activity on natriuretic peptide secretion were studied in isolated perfused rat atria and cultured rat neonatal cardiomyocytes. In isolated rat atrium pacing induced an increase in diastolic, systolic, and averaged intracellular free calcium concentration and a frequency-dependent increase in the secretion of both ANP and BNP. The molar ratio of the secreted natriuretic peptides (ANP to BNP) remained nearly constant ( approximately 1000) at all the pacing frequencies tested (1, 3, 6, and 8 Hz). Calmodulin kinase II inhibitor KN-93 (3 mum) did not affect intracellular free calcium concentration but showed a frequency-dependent inhibitory effect on ANP and BNP secretion without a change in ANP to BNP ratio. In the neonatal cardiomyocytes, KN-93 (3 mum) suppressed the secretion and gene expression of both ANP and BNP. Overexpression of constitutively active (T286D) or nuclear (delta(B)) calcium-calmodulin kinase II induced an increase in ANP and BNP gene expression. The results indicate that the calcium-dependent secretion and gene expression of A- and B-type natriuretic peptides are similarly regulated by calmodulin kinase II-dependent mechanisms. This is a plausible mechanism contributing to exercise-induced natriuretic peptide secretion and the augmented secretion in heart dysfunction due to impaired calcium handling.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17332063     DOI: 10.1210/en.2006-1676

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  9 in total

1.  Model of excitation-contraction coupling of rat neonatal ventricular myocytes.

Authors:  Topi Korhonen; Sandra L Hänninen; Pasi Tavi
Journal:  Biophys J       Date:  2009-02       Impact factor: 4.033

2.  Shear stress triggers insertion of voltage-gated potassium channels from intracellular compartments in atrial myocytes.

Authors:  Hannah E Boycott; Camille S M Barbier; Catherine A Eichel; Kevin D Costa; Raphael P Martins; Florent Louault; Gilles Dilanian; Alain Coulombe; Stéphane N Hatem; Elise Balse
Journal:  Proc Natl Acad Sci U S A       Date:  2013-09-24       Impact factor: 11.205

Review 3.  Transient outward potassium channel: a heart failure mediator.

Authors:  Qianwen He; Ying Feng; Yanggan Wang
Journal:  Heart Fail Rev       Date:  2015-05       Impact factor: 4.214

4.  Ca2+-calmodulin-dependent protein kinase II represses cardiac transcription of the L-type calcium channel alpha(1C)-subunit gene (Cacna1c) by DREAM translocation.

Authors:  Jarkko J Ronkainen; Sandra L Hänninen; Topi Korhonen; Jussi T Koivumäki; Reka Skoumal; Sini Rautio; Veli-Pekka Ronkainen; Pasi Tavi
Journal:  J Physiol       Date:  2011-03-28       Impact factor: 5.182

5.  Aberrant interaction of calmodulin with the ryanodine receptor develops hypertrophy in the neonatal cardiomyocyte.

Authors:  Jaya P Gangopadhyay; Noriaki Ikemoto
Journal:  Biochem J       Date:  2011-09-01       Impact factor: 3.857

Review 6.  Oxytocin and Related Peptide Hormones: Candidate Anti-Inflammatory Therapy in Early Stages of Sepsis.

Authors:  Syed Faizan Mehdi; Suma Pusapati; Raja Ram Khenhrani; Muhammad Saad Farooqi; Sobia Sarwar; Ahmad Alnasarat; Nimisha Mathur; Christine Noel Metz; Derek LeRoith; Kevin J Tracey; Huan Yang; Michael J Brownstein; Jesse Roth
Journal:  Front Immunol       Date:  2022-04-29       Impact factor: 8.786

7.  Metabolite Signature in the Carriers of Pathogenic Genetic Variants for Cardiomyopathy: A Population-Based METSIM Study.

Authors:  Rowmika Ravi; Lilian Fernandes Silva; Jagadish Vangipurapu; Maleeha Maria; Joose Raivo; Seppo Helisalmi; Markku Laakso
Journal:  Metabolites       Date:  2022-05-13

8.  Defective regulation of the ryanodine receptor induces hypertrophy in cardiomyocytes.

Authors:  Tomoyo Hamada; Jaya P Gangopadhyay; Adel Mandl; Peter Erhardt; Noriaki Ikemoto
Journal:  Biochem Biophys Res Commun       Date:  2009-01-29       Impact factor: 3.575

9.  AAV9-mediated VEGF-B gene transfer improves systolic function in progressive left ventricular hypertrophy.

Authors:  Jenni Huusko; Line Lottonen; Mari Merentie; Erika Gurzeler; Andrey Anisimov; Atsushi Miyanohara; Kari Alitalo; Pasi Tavi; Seppo Ylä-Herttuala
Journal:  Mol Ther       Date:  2012-10-23       Impact factor: 11.454

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.